Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide

AIM: To gain further insights into the efficacy of SAR425899, a dual glucagon‐like peptide‐1/glucagon receptor agonist, by providing direct comparison with the glucagon‐like peptide‐1 receptor agonist, liraglutide, in terms of key outcomes of glucose metabolism. RESEARCH DESIGN AND METHODS: Seventy...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiavon, Michele, Visentin, Roberto, Göbel, Britta, Riz, Michela, Cobelli, Claudio, Klabunde, Thomas, Dalla Man, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359969/
https://www.ncbi.nlm.nih.gov/pubmed/33822469
http://dx.doi.org/10.1111/dom.14394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359969/
https://www.ncbi.nlm.nih.gov/pubmed/33822469
http://dx.doi.org/10.1111/dom.14394

Ejemplares similares